Die Krebs-Industrie

Cancer will become one of our biggest challenges in the coming years - both humanly and in terms of health policy. Almost every second German will be affected in old age, and scientists predict a 40 percent increase in cancer cases by 2030. Nevertheless, there is enormous ignorance surrounding this widespread disease, from which many benefit: the gray market for obscure remedies, hospitals with their lucrative preventive practices, and the pharmaceutical industry, for which cancer medications, priced at their discretion, represent the largest growth sector. Karl Lauterbach, a physician and politician, exposes what is going wrong in the healthcare system: the unfair two-tier medicine, especially in cancer care, the wrong financial incentives for clinics and the pharmaceutical industry, and a lack of transparency regarding treatment successes and methods. At the same time, Lauterbach points out numerous cancer myths.